BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Deiana S, Gabbani T, Annese V. Biosimilars in inflammatory bowel disease: A review of post-marketing experience. World J Gastroenterol 2017; 23(2): 197-203 [PMID: 28127193 DOI: 10.3748/wjg.v23.i2.197]
URL: https://www.wjgnet.com/1007-9327/full/v23/i2/197.htm
Number Citing Articles
1
Rovshan M. Ismailov, Lieven Pouillon, Christian P. Selinger, Zaytuna D. Khasanova. Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USAExpert Opinion on Biological Therapy 2021; 21(1): 111 doi: 10.1080/14712598.2020.1842355
2
Jukyung Kang, Karthik Pisupati, Alexander Benet, Brandon T. Ruotolo, Steven P. Schwendeman, Anna Schwendeman. Infliximab Biosimilars in the Age of Personalized MedicineTrends in Biotechnology 2018; 36(10): 987 doi: 10.1016/j.tibtech.2018.05.002
3
Daniel J Wong, Eve M Roth, Joseph D Feuerstein, Vitaliy Y Poylin. Surgery in the age of biologicsGastroenterology Report 2019; 7(2): 77 doi: 10.1093/gastro/goz004
4
Klaudia Farkas, Tamás Molnár. A Review on Biosimilar Infliximab, CT-P13, in the Treatment of Inflammatory Bowel DiseaseImmunotherapy 2018; 10(2): 107 doi: 10.2217/imt-2017-0107
5
Maryam Heidari, Sedigheh Pouya, Kaveh Baghaei, Hamid Asadzadeh Aghdaei, Saeed Namaki, Mohammad Reza Zali, Seyed Mahmoud Hashemi. The immunomodulatory effects of adipose‐derived mesenchymal stem cells and mesenchymal stem cells‐conditioned medium in chronic colitisJournal of Cellular Physiology 2018; 233(11): 8754 doi: 10.1002/jcp.26765
6
Saurabh Talathi, Kondal R. Kyanam Kabir Baig. Biosimilars in inflammatory bowel diseaseJournal of Digestive Diseases 2020; 21(11): 610 doi: 10.1111/1751-2980.12940
7
Laszlo Gulacsi, Marta Pentek, Fanni Rencz, Valentin Brodszky, Petra Baji, Zsuzsanna Vegh, Krisztina B Gecse, Silvio Danese, Laurent Peyrin-Biroulet, Peter L. Lakatos. Biosimilars for the Management of Inflammatory Bowel Diseases: Economic ConsiderationsCurrent Medicinal Chemistry 2019; 26(2): 259 doi: 10.2174/0929867324666170406112304
8
Maria Chiara Ditto, Simone Parisi, Marta Priora, Silvia Sanna, Clara Lisa Peroni, Angela Laganà, Antonio D’Avolio, Enrico Fusaro. Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73183-0
9
Murtaza M. Tambuwala, Mohammed N. Khan, Paul Thompson, Paul A. McCarron. Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitisDrug Delivery and Translational Research 2019; 9(1): 14 doi: 10.1007/s13346-018-00597-9
10
José Diego Marques Santos, Juan Nicolás Peña-Sánchez, Sharyle A. Fowler. Patients’ perspectives on medication for inflammatory bowel disease: a mixed-method systematic reviewEuropean Journal of Gastroenterology & Hepatology 2021; 33(9): 1139 doi: 10.1097/MEG.0000000000001861